hr

Sve / OTC Markets / Bioxcel Therapeutics

Bioxcel Therapeutics

Bioxcel Therapeutics

Investiraj bez provizije

Kupuj i prodaj dijelnice za samo 1 €

1D
1T
1M
3M
1G
MAKS.

Informacije i statistika

Dnevni raspon
1D−100,00 %
3M−100,00 %
1T−100,00 %
6M−100,00 %
1M−100,00 %
1G−100,00 %
SIMBOL
BTAIQ
TRŽIŠTE
OTC Markets
ISIN
US09075P2048

Datum

Zatvori

Promjena

Promjena (%)

Otvoreno

Visoko

Nisko

0,060,000 %0,060,070,05
0,070,0114,29 %0,060,080,05
0,070,0228,57 %0,050,070,04
0,050,0120 %0,040,050,04
0,050,0120 %0,040,060,04
0,050,000 %0,050,060,05
0,050,000 %0,050,060,04
0,060,0233,33 %0,040,060,03
0,040,0250 %0,020,040,02
0,07−0,02−28,57 %0,090,090,07
0,120,000 %0,120,130,11
0,11−0,02−18,18 %0,130,200,11
0,140,000 %0,140,140,12
0,160,016,25 %0,150,170,14
0,18−0,03−16,67 %0,210,230,16
0,72−0,03−4,17 %0,750,760,70
0,780,022,56 %0,760,790,74
0,74−0,04−5,41 %0,780,800,71
0,76−0,04−5,26 %0,800,830,75
0,80−0,02−2,5 %0,820,860,79
0,80−0,03−3,75 %0,830,830,80
0,830,044,82 %0,790,860,79
0,79−0,06−7,59 %0,850,900,78
0,89−0,13−14,61 %1,021,030,85
1,190,097,56 %1,101,241,02
1,130,032,65 %1,101,161,07
1,060,109,43 %0,961,080,96
0,93−0,04−4,3 %0,971,020,93
0,930,033,23 %0,900,960,89
0,900,055,56 %0,850,920,84
0,83−0,01−1,2 %0,840,850,80
0,84−0,03−3,57 %0,870,880,84
0,860,000 %0,860,890,86
0,850,044,71 %0,810,880,80
0,810,022,47 %0,790,840,78
0,790,000 %0,790,810,75
0,80−0,04−5 %0,840,850,79
0,85−0,03−3,53 %0,880,880,83
0,870,022,3 %0,850,870,84
0,85−0,04−4,71 %0,890,890,83
0,87−0,01−1,15 %0,880,900,84
0,88−0,03−3,41 %0,910,920,87
0,900,011,11 %0,890,910,86
0,88−0,01−1,14 %0,890,920,84
0,890,033,37 %0,860,890,80
0,87−0,04−4,6 %0,910,930,85
0,92−0,11−11,96 %1,041,050,89
1,030,1514,56 %0,881,170,88
0,880,077,95 %0,810,930,81
0,82−0,01−1,22 %0,830,870,79
0,840,044,76 %0,800,880,74
0,80−0,24−30 %1,041,040,79
1,04−0,07−6,73 %1,111,121,04
1,10−0,25−22,73 %1,351,351,10
1,38−0,01−0,72 %1,391,421,34
1,37−0,01−0,73 %1,381,411,36
1,41−0,01−0,71 %1,421,421,38
1,400,107,14 %1,301,451,29
1,310,064,58 %1,251,311,25
1,25−0,09−7,2 %1,341,341,24
1,310,032,29 %1,281,361,27
1,26−0,02−1,59 %1,281,321,25
1,300,107,69 %1,201,301,20
1,200,000 %1,201,231,17
1,190,000 %1,191,261,18
1,200,043,33 %1,161,201,14
1,160,000 %1,161,261,16
1,140,043,51 %1,101,161,10
1,11−0,01−0,9 %1,121,151,08
1,090,021,83 %1,071,111,06
1,07−0,03−2,8 %1,101,121,05
1,10−0,04−3,64 %1,141,141,09
1,10−0,12−10,91 %1,221,221,10
1,230,075,69 %1,161,271,15
1,16−0,04−3,45 %1,201,201,16
1,190,010,84 %1,181,241,16
1,190,000 %1,191,201,15
1,17−0,11−9,4 %1,281,281,16
1,26−0,05−3,97 %1,311,361,26
1,310,096,87 %1,221,411,22
1,220,097,38 %1,131,231,13
1,13−0,02−1,77 %1,151,171,13
1,140,054,39 %1,091,141,08
1,090,000 %1,091,101,07
1,08−0,07−6,48 %1,151,151,08
1,13−0,03−2,65 %1,161,191,12
1,14−0,03−2,63 %1,171,201,14
1,210,032,48 %1,181,221,16
1,19−0,01−0,84 %1,201,201,17
1,19−0,02−1,68 %1,211,211,17
1,200,000 %1,201,241,19
1,220,000 %1,221,261,19
1,24−0,08−6,45 %1,321,321,21
1,300,053,85 %1,251,371,24
1,25−0,01−0,8 %1,261,311,25
1,260,053,97 %1,211,281,20
1,20−0,03−2,5 %1,231,291,15
1,230,1613,01 %1,071,251,06
1,04−0,02−1,92 %1,061,071,02
1,06−0,04−3,77 %1,101,101,05
1,090,021,83 %1,071,141,07
1,06−0,04−3,77 %1,101,101,06
1,10−0,07−6,36 %1,171,171,09
1,15−0,01−0,87 %1,161,231,13
1,15−0,07−6,09 %1,221,221,15
1,200,086,67 %1,121,211,12
1,150,054,35 %1,101,251,10
1,070,000 %1,071,091,01
1,05−0,02−1,9 %1,071,141,05
1,060,054,72 %1,011,081,01
1,02−0,02−1,96 %1,041,081,01
1,06−0,03−2,83 %1,091,111,06
1,080,000 %1,081,151,07
1,10−0,05−4,55 %1,151,181,08
1,09−0,05−4,59 %1,141,141,06
1,14−0,07−6,14 %1,211,221,12
1,180,032,54 %1,151,221,08
1,22−0,16−13,11 %1,381,411,19
1,340,128,96 %1,221,351,21
1,21−0,06−4,96 %1,271,281,15
1,26−0,15−11,9 %1,411,421,25
1,37−0,04−2,92 %1,411,441,35
1,43−0,02−1,4 %1,451,491,40
1,43−0,03−2,1 %1,461,471,40
1,47−0,06−4,08 %1,531,541,46
1,51−0,09−5,96 %1,601,611,49
1,60−0,01−0,63 %1,611,621,55
1,65−0,04−2,42 %1,691,711,60
1,730,137,51 %1,601,751,59
1,540,042,6 %1,501,581,50
1,49−0,08−5,37 %1,571,611,47
1,55−0,02−1,29 %1,571,601,53
1,570,010,64 %1,561,631,54
1,55−0,13−8,39 %1,681,781,45
1,730,2715,61 %1,461,791,44
1,48−0,08−5,41 %1,561,601,47
1,61−0,21−13,04 %1,821,831,58
1,650,053,03 %1,601,671,57
1,600,000 %1,601,631,54
1,63−0,02−1,23 %1,651,671,59
1,67−0,09−5,39 %1,761,781,63
1,760,084,55 %1,681,771,63
1,660,021,2 %1,641,671,60
1,640,021,22 %1,621,731,59
1,630,063,68 %1,571,631,53
1,57−0,02−1,27 %1,591,621,55
1,620,042,47 %1,581,621,53
1,580,010,63 %1,571,611,53
1,58−0,01−0,63 %1,591,601,52
1,580,021,27 %1,561,601,54
1,54−0,08−5,19 %1,621,631,52
1,62−0,03−1,85 %1,651,651,53
1,660,106,02 %1,561,721,55
1,570,031,91 %1,541,591,47
1,500,128 %1,381,531,38
1,37−0,13−9,49 %1,501,501,36
1,49−0,08−5,37 %1,571,601,45
1,570,000 %1,571,601,48
1,58−0,02−1,27 %1,601,631,56
1,59−0,02−1,26 %1,611,621,52
1,62−0,08−4,94 %1,701,701,60
1,68−0,09−5,36 %1,771,781,67
1,770,010,56 %1,761,791,70
1,77−0,09−5,08 %1,861,861,76
1,82−0,01−0,55 %1,831,871,80
1,81−0,03−1,66 %1,841,841,76
1,84−0,05−2,72 %1,891,961,82
1,890,010,53 %1,882,081,84
1,84−0,07−3,8 %1,911,961,84
1,91−0,10−5,24 %2,012,011,91
1,99−0,06−3,02 %2,052,051,92
2,050,031,46 %2,022,081,93
2,020,020,99 %2,002,021,87
2,010,010,5 %2,002,031,92
2,00−0,04−2 %2,042,041,87
2,040,2311,27 %1,812,121,79
1,74−0,07−4,02 %1,811,821,71
1,790,073,91 %1,721,811,70
1,700,074,12 %1,631,701,59
1,600,074,38 %1,531,601,52
1,530,000 %1,531,581,50
1,56−0,07−4,49 %1,631,641,54
1,66−0,02−1,2 %1,681,701,65
1,710,000 %1,711,731,66
1,73−0,02−1,16 %1,751,751,66
1,74−0,01−0,57 %1,751,791,68
1,73−0,09−5,2 %1,821,881,71
1,830,000 %1,831,851,78
1,80−0,08−4,44 %1,881,901,80
1,880,000 %1,881,941,85
1,87−0,16−8,56 %2,032,031,87
2,01−0,13−6,47 %2,142,171,98
2,07−0,09−4,35 %2,162,192,07
2,190,052,28 %2,142,302,09
2,13−0,08−3,76 %2,212,242,08
2,200,083,64 %2,122,272,07
2,07−0,05−2,42 %2,122,162,05
2,090,178,13 %1,922,111,90
1,910,042,09 %1,871,921,82
1,87−0,22−11,76 %2,092,091,86
2,06−0,11−5,34 %2,172,192,02
2,250,135,78 %2,122,322,10
2,080,146,73 %1,942,141,93
1,91−0,02−1,05 %1,931,961,87
1,950,073,59 %1,882,081,87
1,910,168,38 %1,751,921,72
1,790,052,79 %1,741,901,74
1,74−0,10−5,75 %1,841,871,74
1,840,031,63 %1,811,851,73
1,830,1910,38 %1,641,851,63
1,630,053,07 %1,581,671,53
1,61−0,10−6,21 %1,711,731,56
1,71−0,12−7,02 %1,831,881,67
2,020,125,94 %1,902,071,87
1,930,052,59 %1,882,021,82
1,830,084,37 %1,751,881,68
1,78−0,09−5,06 %1,871,871,75
1,860,010,54 %1,851,931,83
1,86−0,02−1,08 %1,882,001,84
1,90−0,10−5,26 %2,002,001,90
2,050,010,49 %2,042,071,98
2,02−0,07−3,47 %2,092,141,98
2,07−0,11−5,31 %2,182,182,05
2,18−0,10−4,59 %2,282,282,15
2,28−0,06−2,63 %2,342,402,26
2,330,052,15 %2,282,452,24
2,260,062,65 %2,202,282,14
2,220,062,7 %2,162,302,13
2,20−0,05−2,27 %2,252,292,18
2,29−0,04−1,75 %2,332,392,28
2,31−0,15−6,49 %2,462,472,26
2,46−0,23−9,35 %2,692,702,42
2,68−0,02−0,75 %2,702,752,61
2,620,010,38 %2,612,712,52
2,610,041,53 %2,572,642,50
2,54−0,26−10,24 %2,802,802,51
2,780,051,8 %2,732,872,68
2,660,207,52 %2,462,702,46
2,50−0,07−2,8 %2,572,572,42
2,550,041,57 %2,512,612,48
2,53−0,10−3,95 %2,632,692,47
2,640,041,52 %2,602,702,52
2,570,072,72 %2,502,602,50
2,56−0,05−1,95 %2,612,612,48
2,62−0,15−5,73 %2,772,852,52
2,70−0,23−8,52 %2,932,962,66
2,820,217,45 %2,612,852,53
2,580,093,49 %2,492,582,47
2,47−0,28−11,34 %2,752,822,47
2,78−0,11−3,96 %2,892,952,78
2,99−0,01−0,33 %3,003,112,94
3,010,031 %2,983,192,95
2,90−0,08−2,76 %2,983,052,86
2,99−0,17−5,69 %3,163,162,97
3,170,175,36 %3,003,182,92
3,11−0,28−9 %3,393,413,09
3,39−0,14−4,13 %3,533,753,35
3,52−0,08−2,27 %3,603,953,51
3,58−0,35−9,78 %3,933,933,57
4,230,4711,11 %3,764,293,76
3,790,236,07 %3,564,033,56
3,570,092,52 %3,483,723,48
3,62−0,13−3,59 %3,753,753,41
3,80−0,18−4,74 %3,984,203,78
4,05−0,04−0,99 %4,094,093,80
4,100,204,88 %3,904,263,81
3,96−0,95−23,99 %4,915,193,93
5,240,275,15 %4,975,254,74
5,160,265,04 %4,905,184,71
4,98−0,28−5,62 %5,265,604,90
5,230,377,07 %4,865,424,70
5,040,101,98 %4,945,224,46
4,92−0,02−0,41 %4,945,344,78
5,67−1,18−20,81 %6,856,855,47
5,480,8315,15 %4,655,494,18
4,75−0,26−5,47 %5,016,234,61
5,60−1,69−30,18 %7,297,355,19
6,801,1817,35 %5,628,064,81
6,402,0832,5 %4,326,694,27
4,040,4611,39 %3,584,683,57
3,410,247,04 %3,173,703,06
3,320,175,12 %3,153,742,98
2,970,6521,89 %2,323,482,26
2,540,8332,68 %1,712,751,57
1,37−0,28−20,44 %1,652,061,33
1,31−0,17−12,98 %1,481,501,30
1,43−0,14−9,79 %1,571,581,39
1,59−0,14−8,81 %1,731,751,57
1,70−0,09−5,29 %1,791,811,65
1,810,031,66 %1,781,831,75
1,73−0,04−2,31 %1,771,801,69
1,810,000 %1,811,871,75
1,80−0,12−6,67 %1,921,921,74
1,89−0,05−2,65 %1,941,951,88
1,91−0,03−1,57 %1,942,001,88
1,940,000 %1,941,981,88
1,950,042,05 %1,912,001,86
1,90−0,30−15,79 %2,202,271,88
2,020,041,98 %1,982,071,90
1,97−0,03−1,52 %2,002,051,91
2,000,000 %2,002,141,99
1,99−0,01−0,5 %2,002,101,96
2,010,136,47 %1,882,031,81
1,90−0,07−3,68 %1,972,001,83
1,93−0,05−2,59 %1,981,981,92
1,93−0,06−3,11 %1,992,001,88
1,970,063,05 %1,912,001,86
1,810,021,1 %1,791,851,69
1,77−0,31−17,51 %2,082,081,75
2,030,031,48 %2,002,031,83
2,050,125,85 %1,932,221,81
1,73−0,05−2,89 %1,781,831,63
1,650,042,42 %1,611,721,58
1,60−0,18−11,25 %1,781,871,60
1,730,095,2 %1,641,801,64
1,64−0,05−3,05 %1,691,731,61
1,690,1911,24 %1,501,721,50
1,56−0,14−8,97 %1,701,701,53
1,770,010,56 %1,761,801,71
1,79−0,24−13,41 %2,032,031,78
1,990,000 %1,992,111,97
1,960,115,61 %1,852,011,85
1,840,2815,22 %1,561,841,55
1,53−0,01−0,65 %1,541,581,44
1,530,159,8 %1,381,531,36
1,370,042,92 %1,331,441,31
1,320,139,85 %1,191,371,18
1,18−0,02−1,69 %1,201,211,17
1,23−0,03−2,44 %1,261,311,21
1,26−0,11−8,73 %1,371,371,25
1,390,000 %1,391,411,30
1,390,032,16 %1,361,421,30
1,37−0,04−2,92 %1,411,431,34
1,39−0,01−0,72 %1,401,481,36
1,42−0,03−2,11 %1,451,451,40
1,440,010,69 %1,431,461,39
1,450,000 %1,451,511,42
1,460,074,79 %1,391,501,35
1,37−0,06−4,38 %1,431,471,33
1,43−0,05−3,5 %1,481,501,35
1,48−0,10−6,76 %1,581,581,43
1,53−0,07−4,58 %1,601,641,50
1,580,063,8 %1,521,591,50
1,53−0,04−2,61 %1,571,601,50
1,58−0,13−8,23 %1,711,741,56
1,71−0,08−4,68 %1,791,821,67
1,78−0,06−3,37 %1,841,881,74
1,77−0,13−7,34 %1,901,951,75
1,85−0,13−7,03 %1,981,981,78
1,990,084,02 %1,912,091,91
1,960,063,06 %1,901,981,87
1,87−0,02−1,07 %1,891,901,80
1,850,115,95 %1,741,871,73
1,69−0,03−1,78 %1,721,731,65
1,68−0,09−5,36 %1,771,771,60
1,710,000 %1,711,741,62
1,74−0,14−8,05 %1,881,911,69
1,820,021,1 %1,801,861,76
1,82−0,12−6,59 %1,942,001,82
1,920,105,21 %1,821,951,77
1,810,179,39 %1,641,831,64
1,64−0,16−9,76 %1,801,811,60
1,790,3217,88 %1,471,791,36
1,47−0,17−11,56 %1,641,671,44
1,560,2113,46 %1,351,591,29
Prikaži više

Prikazani podaci odnose se na razdoblje 07. tra 2025. – 18. ruj 2026..
Promjena, otvaranje, zatvaranje te visoke i niske vrijednosti temelje se na dnevnoj kupovnoj cijeni BTAIQ.

Povezane rasprave

Radar19

prije 3 tjedna

Min +100%

Company by this prices valued 4 mln got almost 40 mln credits. Has idea's.. Who so full... Or so trust?

Sparcks

prije 3 tjedna

OTC

Nasdaq will suspend trading of BTAI on September 8, 2026, and the company says it doesn't plan to contest the delisting. After that, the shares are expected to move to OTC Pink Limited Thats why the price drop , i think we go down more

Sparcks

prije 3 tjedna

i dont understant anymore

who sell? why this price tank so mytch , we going to zero ?

Sparcks

prije 3 tjedna

9 oct is the date

October 9, 2026 → the deadline for submitting bids ("Qualified Bids") that can compete with Teva's offer. October 14, 2026 → is the scheduled date for the auction, if needed. If a better offer comes in by October 9, Teva can overbid, and the other bidders can keep competing in the auction. After the auction, the result still has to be approved by the bankruptcy court, so October 14 doesn’t necessarily mean the deal will be finally closed that day. So during this time the stock price might fluctuate , good luck all

Radar19

prije 3 tjedna

Short comment

Now company is on better situation than before Chapter 11. But price is 4 times lower. Question... How long it will be on this low level?

Radar19

prije 3 tjedna

1st target 0.24

Check last 24h.. News.. Selling assets min 57 mln

StockyMan

prije 3 tjedna

Watch this

With a predicted analyst price of 18$ someone is gonna buy this at the last minute so holding on because the drug is too good to lose so soon before approval watch this space DYOR!

pedrothecat

prije 3 tjedna

🤑

I bought 100 quid worth of shares at these levels Give a mad man money don’t be surprised when he does some mad SH-T

Sparcks

prije 3 tjedna

ITS DONE

it's over, the bullies will sell iglamy and we will lose all our money, only a miracle will come for another buyer to offer more, a few days ago a member of the management left for another company, I think he knew what was coming, so only a miracle can save us, another buyer has to come and offer over 100 million for us to receive something, the management will receive their salaries and bonuses so for them I don't think it's too big a loss!!

Sparcks

prije 3 tjedna

Game over

Guest thats it, shorters won , i think btai cant pay and ppl start to sell

Sparcks

prošli mjesec

55% Off Premium BioXcel’s BXCL501 Agitation Study Completion: What Investors Should Watch Next

https://www.tipranks.com/news/company-announcements/bioxcels-bxcl501-agitation-study-completion-what-investors-should-watch-next

Oliver11

prije 2 mjeseca

Moon 🌕

News inc. I hope, huge potential

Nitrocooler

prije 2 mjeseca

Snapshot

Snapshot

Oliver11

prije 2 mjeseca

Movement

Any idea where we could go tdy?

Kennyup

prije 3 mjeseca

One to watch

$BTAI has had great success in phase 1, 2 and 3 trails. The PDUFA decision has a target date of novemeber the 14th 2026 I expect speculative volume getting closer to the decision date. Be aware if approved the stock could lock in some highly significant gains. There is always risk involved if denied it could experience a heavy drop. Good luck and safe trading👍 NFA

Sparcks

prije 3 mjeseca

BioXcel Therapeutics, Inc.(NasdaqCM:BTAI) added to Russell 3000E Growth Benchmark

Good news

Na ovoj se stranici možda nalazi sadržaj koji je izradila zajednica za koji platforma Trading 212 nije odgovorna. Uvijek sami provjerite sve informacije. Trading 212 pruža samo uslugu izvršenja i ne nudi investicijske savjete ili upravljanje portfeljem.

Povezani instrumenti

Orion

−0,15 (−0,32 %)

Sanofi

−0,41 (−0,96 %)

Fate Therapeutics

+0,04 (+1,61 %)

Stoke Therapeutics

−3,50 (−10,96 %)

Insmed

−12,55 (−9,47 %)

Monte Rosa Therapeutics

−3,58 (−22,79 %)

BridgeBio Pharma

−16,19 (−19,55 %)

Passage Bio

+0,35 (+7,95 %)

China Pharma

−0,5000 (−41,32 %)

Johnson & Johnson

+13,01 (+5,06 %)

Ultragenyx Pharmaceutical

−11,31 (−43,80 %)

CEL-SCI

+0,05 (+3,11 %)

Ulaganje bez provizije za sve

Kupuj i prodaj Bioxcel Therapeutics Inc −0,0096 $ (14,2 %) i više od 13.000 globalnih dionica i ETF-ova

Možda se primjenjuju druge naknade. Pogledaj naše uvjete i naknade.

Pogledaj naše uvjete i naknade ovdje

phone

Odmah kupi dionice

Odaberi svoju omiljenu tvrtku

Odluči koliko želiš uložiti

Preuzmi dionice za nekoliko sekundi

Izgradnja bogatstva je navika.
Automatiziraj je pomoću pie.

Uloži u gotove pies ili stvori vlastite odabirom među tisućama dionica i ETF-ova

Saznaj više

Saznaj više

Pogledaj video

Kupi čak i najskuplje dionice kao što su Google, Amazon i Apple

Pogledaj video

Flag fr

Euronext
Pariz

Flag us

NYSE,
NASDAQ

Flag de

Xetra,
Gettex

Flag nl

Euronext Amsterdam

Flag es

Bolsa
de Madrid

Flag at

Wiener
Börse

Flag uk

Londonska burza

Flag pt

Euronext Lisabon

Flag fr

Euronext
Pariz

Flag us

NYSE,
NASDAQ

Flag de

Xetra,
Gettex

Flag nl

Euronext Amsterdam

Flag es

Bolsa
de Madrid

Flag at

Wiener
Börse

Flag uk

Londonska burza

Flag pt

Euronext Lisabon

Prikaži sve instrumente trgovanja

Podrška 24/7

Prosječno vrijeme odgovora iznosi 29 sekundi

Počni graditi svoje bogatstvo sada

Pridruži se zajednici od 5 milijuna korisnika

Preuzmi aplikaciju

Otvori račun

Preuzmi mobilnu aplikaciju

qr-code

Svi prikazani statistički podaci su globalni. Broj klijenata predstavlja financirane račune.

Izvrsno

Ocjena 4,6 / 5 na osnovi 103.187 recenzije/a s platforme

Trustpilot

Ocjena 4,6 / 5 na osnovi 103.187 recenzije/a s platforme

Trustpilot

Pozvan

Easy to understand + use

Feel confident that my money is safe and invested carefully

Mark Smith

Prije 5 dana

Pozvan

New Account

Easy to open an account and the app is straightforward and informative

Bubs

Prije 5 dana

Pozvan

My money is growing so much quicker in…

My money is growing so much quicker in this account than any other. The app is so easy to use!

claire randall

Prije 5 dana

Pozvan

Ease of use for beginners and minute by…

Ease of use for beginners and minute by minute updates. Also, news bulletins are great to follow.

The McCormicks

Prije 6 dana

Pozvan

Easy to use

Easy to use. Lots of info on stocks. I’m a beginner only trading from August 2025. And making some profits through the year.

Stephen Morrow

Prije 6 dana

Pozvan

Great app!

Great app!! Simple & intuitive!!

Stevo Lan

Prije 6 dana

Pozvan

Cash ISA investment

It has been very easy to make the investment in a cash ISA and track it on the app.

Fiona

Prije 6 dana

Pozvan

Really easy to use, great app

Really easy to use, transfers are super quick and the interest rate is phenomenal. Great app.

Christine Thompson

Prije 6 dana

Pozvan

The App is excellent.

The App is excellent and very secure.

Stephen jones

Prije 6 dana

Pozvan

I like the way they keep you informed.

I like the way they keep you informed.

customer

Prije 6 dana

Pozvan

Excellent ISA Experience

ISA Fractional shares at low cost and great app with lots of markets. My held cash gets excellent interest rate. This helps me to wait for the right moment before investing.

Richard Sullivan

Prije 6 dana

Best broker app by far

I’ve had an excellent experience with Trading 212. The app is exceptionally well designed, with a clean, intuitive UI that makes investing feel simple without compromising on functionality. I particularly love features like Pies, which make it incredibly easy to build and manage a diversified portfolio, as well as the clear and well-presented performance metrics. It’s easy to understand how your investments are performing at a glance, which is something many other platforms struggle to get right. The fees are also very competitive, making Trading 212 particularly attractive for long-term investors. The combination of low costs, excellent functionality, interests paid daily on uninvested cash and a genuinely user-friendly experience makes it the best investing platforms I’ve used. Overall, a fantastic app that keeps adding useful features while remaining incredibly easy to use. Highly recommended for both beginners and more experienced investors.

Victor Poirette

Prije 12 dana

Pozvan

Keeping it low cost and simple

Great for both cash and stocks & shares ISA's as well as SIPP's

Bradley Masters

Prije 12 dana

Pozvan

Kept well informed on how my investment…

Kept well informed on how my investment is progressing

Ann Armstrong

Prije 12 dana

Pozvan

Simple to use for someone like me

Simple to use for someone like me . Easy to add or withdraw

Tracey

Prije 12 dana

Pozvan

I love it

I love it, watching the interest being added every day, being able to take money out when short abd putting as much as you can in when ever you want. I find it good to help my self be careful with money. I tell everybody how good it is.

Karen Phillips

Prije 12 dana

Pozvan

Easy to use

Easy to use, love seeing the interest increasing each day. Simple to install on iPhone, although tricky on android

Liz Robbins

Prije 12 dana

Pozvan

Good Shares ISA

Have used a zero fee competitor. Trading 212 beats them for speed of deposits and withdrawals. They also charge a lower fee for currency conversions. Transfer in of a cash ISA was efficiently handled. Make sure you use instant bank transfers, rather than cards or ApplePay for deposits. Cards work fine until you exceed a lifetime total deposit of £2000 (after which they have a 0.7% fee).

and184and

Prije 12 dana

Pozvan

Great for nervous newbie investors

I have been very pleasantly surprised at the good selection of ETF’s and company shares available on this platform. Armed with a little information gleaned from you tube videos I found the site simple to navigate and the purchasing tools very easy and intuitive. I can place an instruction to sell or purchase at a particular price point which I really like. I can track prices on my own investments and also monitor other potential investments. My only regret is that I didn’t sign up sooner.

PoshPolly

Prije 13 dana

Pozvan

Great service with best initial interezt rate

Good interest rate, clear display of account status, easy to explore website, timely execution of withdrawal requests

Jennifer

Prije 13 dana

Prikazuju se neke od pozitivnih recenzija naših klijenata

Naše nagrade

Česta pitanja

Koja je cijena dionice Bioxcel Therapeutics?

Trenutna cijena Bioxcel Therapeutics je 0,06 $.

Koji je 52-tjedni maksimum za Bioxcel Therapeutics?

52-tjedni maksimum za Bioxcel Therapeutics je 2,96 $.

Koji je 52-tjedni minimum za Bioxcel Therapeutics?

52-tjedni minimum za Bioxcel Therapeutics je 0,02 $.

Kakva je tjedna učinkovitost Bioxcel Therapeutics?

U proteklom tjednu cijena Bioxcel Therapeutics promijenila se za 28,32 %.

Kakva je mjesečna učinkovitost Bioxcel Therapeutics?

Tijekom proteklog mjeseca, cijena Bioxcel Therapeutics promijenila se za −93,48 %.

Kakva je 3-mjesečna performansa Bioxcel Therapeutics?

U posljednja tri mjeseca cijena Bioxcel Therapeutics promijenila se za −95,13 %.

Kakva je 6-mjesečna performansa Bioxcel Therapeutics?

U posljednjih šest mjeseci cijena Bioxcel Therapeutics promijenila se za −96,65 %.

Kakva je godišnja učinkovitost Bioxcel Therapeutics?

Tijekom protekle godine cijena Bioxcel Therapeutics promijenila se za −98 %.